559 results on '"Willemze, Roel"'
Search Results
2. Neutrophils Are Indispensable for Hematopoietic Stem Cell Mobilization Induced by Interleukin-8 in Mice
3. Dual HLA Class I and Class II Restricted Recognition of Alloreactive T Lymphocytes Mediated by a Single T Cell Receptor Complex
4. Prevention of Interleukin-8-Induced Mobilization of Hematopoietic Progenitor Cells in Rhesus Monkeys by Inhibitory Antibodies against the Metalloproteinase Gelatinase B (MMP-9)
5. T Cells Recognizing Leukemic CD34 + Progenitor Cells Mediate the Antileukemic Effect of Donor Lymphocyte Infusions for Relapsed Chronic Myeloid Leukemia after Allogeneic Stem Cell Transplantation
6. The Early Phase of Engraftment after Murine Blood Cell Transplantation is Mediated by Hematopoietic Stem Cells
7. Supplementary Tables 1-3 from High-Throughput Characterization of 10 New Minor Histocompatibility Antigens by Whole Genome Association Scanning
8. Data from High-Throughput Characterization of 10 New Minor Histocompatibility Antigens by Whole Genome Association Scanning
9. Supplementary Figure 1 from High-Throughput Characterization of 10 New Minor Histocompatibility Antigens by Whole Genome Association Scanning
10. Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013)
11. Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
12. EORTC Leukemia Group achievements
13. Identification of Phosphatidylinositol 4-Kinase Type II β as HLA Class II-Restricted Target in Graft versus Leukemia Reactivity
14. Serpina1 Is a Potent Inhibitor of IL-8-Induced Hematopoietic Stem Cell Mobilization
15. Clinical and biological impact of TET2 mutations and expression in younger adult AML patients treated within the EORTC/GIMEMA AML-12 clinical trial
16. Co-ordinated isolation of CD8+ and CD4+ T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy
17. HLA-DPB1 Mismatching Results in the Generation of a Full Repertoire of HLA-DPB1-Specific CD4 + T Cell Responses Showing Immunogenicity of all HLA-DPB1 Alleles
18. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
19. Identification of 4 new HLA-DR–restricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity
20. Modification of Rhodamine Staining Allows Identification of Hematopoietic Stem Cells with Preferential Short-Term or Long-Term Bone Marrow-Repopulating Ability
21. Neutrophil Kinetics and the Regulation of Granulopoiesis
22. Identification of phosphatidylinositol 4-kinase type II [beta] as HLA class II-restricted target in graft versus leukemia reactivity
23. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia
24. Identification of the angiogenic endothelial-cell growth factor-1/thymidine phosphorylase as a potential target for immunotherapy of cancer
25. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice
26. Effect of centre on outcome of bone-marrow transplantation for acute myeloid leukaemia
27. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9)
28. Use of glycosylated recombinant human G-CSF (lenograstim) during and/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study
29. T cells recognizing leukemic CD34+ progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation
30. The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells
31. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population
32. α-Interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease
33. Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia
34. Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization
35. Modification of rhodamine staining allows identification of hematopoietic stem cells with preferential short-term or long-term bone marrow-repopulating ability
36. Autologous or allogenic bone marrowtransplantation compared with intensive chemotherapy in acute myelogenous leukemia
37. Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
38. A simplified assay for measurement of cytosine arabinoside incorporation into DNA in Ara-C-sensitive and-resistant leukemic cells
39. Deoxycytidine kinase expression and activity in patients with resistant versus sensitive acute myeloid leukemia
40. Long-term follow-up of recipients of allogeneic bone marrow grafts reveals no progressive telomere shortening and provides no evidence for haematopoietic stem cell exhaustion
41. Expression of co-stimulatory and adhesion molecules and chemokine or apoptosis receptors on acute myeloid leukaemia: high CD40 and CD11a expression correlates with poor prognosis
42. The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
43. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region
44. Ex Vivo Expansion and Engraftment Potential of Cord Blood-Derived CD34+ Cells in NOD/SCID Mice
45. Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial
46. Response to interferon alfa-2b in a patient with systemic mastocytosis
47. Inactivation of deoxycytidine kinase and overexpression of P-glycoprotein in AraC and daunorubicin double resistant leukemic cell lines
48. Aplastic anaemia in donor cells 14 years after bone-marrow transplant
49. Biology of IL-8-Induced Stem Cell Mobilization
50. Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.